+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biodesix Inc (BDSX) - Product Pipeline Analysis, 2021 Update

  • ID: 5367363
  • Company Profile
  • June 2021
  • 40 pages
  • GlobalData

FEATURED COMPANIES

  • Cardiocom LLC
  • CardioDx Inc
  • Foundation Medicine Inc
  • Roka Bioscience Inc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. The company collaborates with leading researchers to develop companion diagnostics for use with therapeutic agents and work in partnership with biotechnology and pharmaceutical companies such as Aveo Oncology and Biognosys. Biodesix is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biodesix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cardiocom LLC
  • CardioDx Inc
  • Foundation Medicine Inc
  • Roka Bioscience Inc
  • MORE
Biodesix Inc Company Overview
  • Biodesix Inc Company Snapshot
  • Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biodesix Inc - Pipeline Analysis Overview
  • Biodesix Inc - Key Facts
  • Biodesix Inc - Major Products and Services
  • Biodesix Inc Pipeline Products by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc Pipeline Products Overview
  • 52-Gene NGS Test - NSCLC
  • 52-Gene NGS Test - NSCLC Product Overview
  • 52-Gene Panel Based Companion Diagnostic
  • 52-Gene Panel Based Companion Diagnostic Product Overview
  • AI-Based Algorithm - COVID-19
  • AI-Based Algorithm - COVID-19 Product Overview
  • Biodesix Collection Device
  • Biodesix Collection Device Product Overview
  • Companion Diagnostic Test - NSCLC
  • Companion Diagnostic Test - NSCLC Product Overview
  • HIV Diagnostic Test
  • HIV Diagnostic Test Product Overview
  • HRM-MS Based Companion Diagnostic Test
  • HRM-MS Based Companion Diagnostic Test Product Overview
  • Multiplexed Proteomic Assay - Alzheimer’s Disease
  • Multiplexed Proteomic Assay - Alzheimer’s Disease Product Overview
  • PD-L1 Blood Based Diagnostic Test
  • PD-L1 Blood Based Diagnostic Test Product Overview
  • PD-L1 Blood Based Diagnostic Test Clinical Trial
  • TAm-Seq NGS Lung Cancer Test
  • TAm-Seq NGS Lung Cancer Test Product Overview
  • VeriStrat - Breast Cancer
  • VeriStrat - Breast Cancer Product Overview
  • VeriStrat - Colorectal Cancer
  • VeriStrat - Colorectal Cancer Product Overview
Biodesix Inc - Key Competitors

Biodesix Inc - Key Employees

Biodesix Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Biodesix Inc, Recent Developments
  • Jun 17, 2021: Biodesix announces presentation on novel proteomic techniques in partnership with Seer
  • May 11, 2021: Biodesix Announces First Quarter 2021 Results
  • Apr 26, 2021: Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021
  • Apr 06, 2021: Biodesix announces issuance of two U.S. Patents, expands coverage of diagnostic methods to improve care for cancer patients
  • Mar 16, 2021: Biodesix Announces Fourth Quarter and Full Year 2020 Results
  • Feb 16, 2021: Biodesix partners with Chicago Public Schools for COVID-19 testing to safely reopen schools
  • Feb 12, 2021: Biodesix to Participate in Two February Conferences
  • Jan 26, 2021: Biodesix to showcase new data on patient immune profiling from multiple studies at World Lung Conference
  • Jan 30, 2020: Biodesix, Streck sign agreement to secure FDA approval for products
  • Nov 05, 2019: Biodesix appoints Scott Hutton as chief executive officer
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biodesix Inc Pipeline Products by Equipment Type
  • Biodesix Inc Pipeline Products by Indication
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
  • Biodesix Inc, Key Facts
  • Biodesix Inc, Major Products and Services
  • Biodesix Inc Number of Pipeline Products by Development Stage
  • Biodesix Inc Pipeline Products Summary by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
  • Biodesix Inc Ongoing Clinical Trials Summary
  • 52-Gene NGS Test - NSCLC - Product Status
  • 52-Gene NGS Test - NSCLC - Product Description
  • 52-Gene Panel Based Companion Diagnostic - Product Status
  • 52-Gene Panel Based Companion Diagnostic - Product Description
  • AI-Based Algorithm - COVID-19 - Product Status
  • AI-Based Algorithm - COVID-19 - Product Description
  • Biodesix Collection Device - Product Status
  • Biodesix Collection Device - Product Description
  • Companion Diagnostic Test - NSCLC - Product Status
  • Companion Diagnostic Test - NSCLC - Product Description
  • HIV Diagnostic Test - Product Status
  • HIV Diagnostic Test - Product Description
  • HRM-MS Based Companion Diagnostic Test - Product Status
  • HRM-MS Based Companion Diagnostic Test - Product Description
  • Multiplexed Proteomic Assay - Alzheimer’s Disease - Product Status
  • Multiplexed Proteomic Assay - Alzheimer’s Disease - Product Description
  • PD-L1 Blood Based Diagnostic Test - Product Status
  • PD-L1 Blood Based Diagnostic Test - Product Description
  • PD-L1 Blood Based Diagnostic Test - A Study to Evaluate the Clinical Utility of Biomarkers, Including the Proteomic Primary Immune Response (PIR) Test, for Front-line Non-small Cell Lung Cancer (NSCLC) Patients Receiving Immunotherapy with and without the Addition of Systemic Platinum-based Chemotherapy who Have High Expression of Program Death Ligand-1 (PD-L1) on Their Tumor Cells
  • PD-L1 Blood Based Diagnostic Test - Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated with PD-1/PD-L1 Based Therapy with or without the Addition of Platinum Based Chemotherapy
  • TAm-Seq NGS Lung Cancer Test - Product Status
  • TAm-Seq NGS Lung Cancer Test - Product Description
  • VeriStrat - Breast Cancer - Product Status
  • VeriStrat - Breast Cancer - Product Description
  • VeriStrat - Colorectal Cancer - Product Status
  • VeriStrat - Colorectal Cancer - Product Description
Biodesix Inc, Key Employees
  • Biodesix Inc, Subsidiaries
  • Glossary
List of Figures
  • Biodesix Inc Pipeline Products by Equipment Type
  • Biodesix Inc Pipeline Products by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Roka Bioscience Inc
  • Foundation Medicine Inc
  • Cardiocom LLC
  • CardioDx Inc
Note: Product cover images may vary from those shown
Adroll
adroll